Intravenous Bisphosphonates Linked to Increased Short-Term Uveitis Risk: Insights from a Nationwide Taiwan Study

Intravenous bisphosphonates, particularly zoledronic acid, significantly increase short-term uveitis risk.
No significant associations were found between bisphosphonates and scleritis or cystoid macular edema (CME).
Oral bisphosphonates do not appear to raise the risk of inflammatory eye reactions.
Case-case-time-control methodology accounted for temporal trends, strengthening causality insights.

Specialty calculators

For clinical reference; use professional judgment.